Low post chemoradiotherapy plasma osteopontin level may be marker of clinical benefit in inoperable squamous cell head and neck carcinoma patients - Snitcovsky, I.; Bruniati, K.; Leitão, G.; Pasini, F.; Federico, M.; Castro, G.; Carreiro, K.; Campoflorito, C.; Villar, R.; Mangone, F.; Maistro, S. (Oral Oncology Head and Neck Oncology & Pathology, 2007)